Physician profile
Beth Gachuki
NPI 1811479439
$717.93
in general payments reported to CMS, 2019-2025
11 companies · $30.36 in 2025
The $30.36 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $181 · 2023: $59.50 · 2025: $30.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $327.05 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $151.83 | 2021-2025 | Airsupra |
| Sunovion Pharmaceuticals INC. | $48.00 | 2021 | |
| Esperion Therapeutics, INC. | $42.57 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.37 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $29.55 | 2021 | |
| Medtronic, INC. | $20.48 | 2021 | |
| Amgen INC. | $20.06 | 2021 | |
| Alkermes, INC. | $19.19 | 2022 | |
| Uswm, LLC | $14.30 | 2021 | |
| Pfizer INC. | $13.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Gachuki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.